Home › NDC Lookup › Ingredients › Chelidonium, Euphrasia, Kali Sulph, Natr... › 17312-0478-14
⚪image loading
(from DailyMed)

Natural Eyes Floaters Relief Chelidonium, Euphrasia, Kali sulph, Natrum muriaticum, Phosphorus, Physostigma, Sepia, Silicea 10 [hp_X]/1; 10 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1; 7 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1 Tablet, 70-count

by TRP Company · 1 BOTTLE in 1 PACKAGE (17312-478-14) / 70 TABLET in 1 BOTTLE
NDC 17312-0478-14
🏷️ FDA NDC (as labeled) 17312-478-14 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 17312-478-14
Product NDC 17312-478
11-digit billing NDC 17312047814
UNII 451W47IQ8X, 1K573LC5TV, C9642I91WL, CJV9E9IIOA, ETJ7Z6XBU4, QDL83WN8C2 +2 more
SPL Set ID 445dc831-195e-4b25-e063-6294a90a6efd
Mechanism of action Osmotic Activity
Physiologic effect Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-04-28
Route ORAL
Dosage form TABLET
Substance SODIUM CHLORIDE; POTASSIUM SULFATE; EUPHRASIA STRICTA; PHYSOSTIGMA VENENOSUM SEED; SILICON DIOXIDE; SEPIA OFFICINALIS JUICE; CHELIDONIUM MAJUS; PHOSPHORUS
Why two NDCs? The FDA registers this code as 17312-478-14 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 17312-0478-14. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerTRP Company
Labeler code17312
First marketedApr 2025
Product typeHuman Otc Drug
Portfolio31 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Natural Eyes Floaters Relief is an unapproved homeopathic tablet taken by mouth. It contains eight substances (including sodium chloride, potassium sulfate, and silicon dioxide) that are used in homeopathic practice. In homeopathic tradition, these ingredients are selected based on classical homeopathic theory rather than clinical evidence. Homeopathic products are not evaluated by the FDA for effectiveness, and their use is based on homeopathic principles, not established medical science.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
ShapeDiamond
ImprintTRP
Size13 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII D9C330MD8B
    Copovidone is a synthetic polymer made by combining two types of plastic-like molecules. It acts as a binder and film-former to help hold tablet ingredients together and improve how the medicine dissolves in your body.
  • UNII 68401960MK
    Crospovidone is a synthetic polymer made from polyvinylpyrrolidone. It acts as a disintegrant, helping tablets break apart quickly in the stomach so the medicine dissolves and absorbs into the body.
  • UNII J2B2A4N98G
    Lactose is a natural sugar derived from milk. In medications, it serves as a filler and binder to add bulk and help hold tablet or capsule ingredients together during manufacturing.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients Copovidone, Crospovidone, Lactose, Magnesium stearate, Mannitol, Microcrystalline cellulose, Silicon dioxide, Sorbitol.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Natural Eyes Floaters Relief 10 [hp_X]/1; 10 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1; 7 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]this 17312-0478-14 TRP 70 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2025
On the market since
Apr 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
17312-0478-14 You're viewing this 1 BOTTLE in 1 PACKAGE (17312-478-14) / 70 TABLET in 1 BOTTLE 2025-04-28 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Natural Eyes Floaters Relief Chelidonium, Euphrasia, Kali sulph, Natrum muriaticum, Phosphorus, Physostigma, Sepia, Silicea 10 [hp_X]/1; 10 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1; 7 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1 TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 17312-478-14, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 17312-0478-14, written without dashes as 17312047814. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 17312-0478-14, the first segment (17312) is the labeler code FDA assigned to TRP Company; the middle segment (0478) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (14) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by TRP Company. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
TRP Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 42 words ▾

Uses* According to homeopathic indications these ingredients provide temporary relief from eye floaters after serious causes have been ruled out by a physician. *These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

⏱️ Dosage and Administration 67 words ▾

Directions: Suitable for adults and children 5 years and over. Dissolve entire tablet under tongue. Do not chew or swallow whole. Take 2 tablets a day or as directed by a physician. Use up to 6 times a day as needed. Take at least 10 minutes before or at least 10 minutes after eating or drinking. Children under the age of 5: Consult a physician before use.

⚠️ Warnings 128 words ▾

Warnings: A PHYSICIAN SHOULD ALWAYS BE CONSULTEDTO RULE OUT SERIOUS CAUSES. This product is intended to complement, not replace, standard medical treatment. Initial worsening of symptoms may occur.

This product is intended to be taken orally. Do not use in eyes or nose. If pregnant or breast-feeding, ask a health professional before use.

Do not use if: You frequently contract infections that do not clear up easily. You experience eye pain or changes in vision. Keep out of reach of children.

In case of accidental overdose, get medical help or contact a Poison Control Center right away. Stop use and ask a doctor if: You experience eye pain or change in vision, continued floaters, or irritation of the eye. The condition worsens.

Symptoms last longer than 72 hours.

🧪 Active Ingredient 47 words ▾

Active ingredients Chelidonium HPUS 6X Euphrasia HPUS 6X Kali sulph. HPUS 10X Natrum muriaticum HPUS 10X Phosphorus HPUS 12X Physostigma HPUS 12X Sepia HPUS 7X Silicea HPUS 12X “HPUS” indicates the active ingredients of this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.

🧪 Inactive Ingredients 13 words ▾

Inactive ingredients Copovidone, Crospovidone, Lactose, Magnesium stearate, Mannitol, Microcrystalline cellulose, Silicon dioxide, Sorbitol.

🎯 Purpose 42 words ▾

Purpose Chelidonium - Floaters obstructing vision Euphrasia - Irritation Kali sulph. - Squiggly lines in vision Natrum muriaticum - Floaters in vision Phosphorus - Dark dots in vision Physostigma - Shapes in vision Sepia HPUS - Dust particles Silicea HPUS - Floaters

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 17312-0477-30 · TRP 17314-0215-00 · Janssen →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.